Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea.

Stokes NR, Dietz BW, Liang JJ.

Open Access Emerg Med. 2016 May 17;8:35-45. doi: 10.2147/OAEM.S71446. eCollection 2016. Review.

2.

Predicting the occurrence of major adverse cardiac events within 30 days of a vascular surgery: an empirical comparison of the minimum p value method and ROC curve approach using individual patient data meta-analysis.

Vanniyasingam T, Rodseth RN, Lurati Buse GA, Bolliger D, Burkhart CS, Cuthbertson BH, Gibson SC, Mahla E, Leibowitz DW, Biccard BM, Thabane L.

Springerplus. 2016 Mar 9;5:304. doi: 10.1186/s40064-016-1936-8. eCollection 2016.

3.

The usefulness of brain natriuretic peptide level in diagnosis and prognosis of patients admitted to critical care unit with shortness of breath.

Abdeen Y, Sen P, Safdar S, Katapally R, Arqoob AA, Macbruce D, Shaaban H, Adelman M.

J Emerg Trauma Shock. 2015 Oct-Dec;8(4):205-9. doi: 10.4103/0974-2700.166611.

4.

Considerations for initial therapy in the treatment of acute heart failure.

Peacock WF, Cannon CM, Singer AJ, Hiestand BC.

Crit Care. 2015 Nov 10;19:399. doi: 10.1186/s13054-015-1114-3. Review.

5.

Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis.

Kunin M, Carmon V, Arad M, Levin-Iaina N, Freimark D, Holtzman EJ, Dinour D.

Biomed Res Int. 2015;2015:590851. doi: 10.1155/2015/590851. Epub 2015 Oct 11.

6.

Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool.

Collins SP, Jenkins CA, Harrell FE Jr, Liu D, Miller KF, Lindsell CJ, Naftilan AJ, McPherson JA, Maron DJ, Sawyer DB, Weintraub NL, Fermann GJ, Roll SK, Sperling M, Storrow AB.

JACC Heart Fail. 2015 Oct;3(10):737-47. doi: 10.1016/j.jchf.2015.05.007.

7.

The value of (NT-pro) BNP in the diagnosis, prognosis and treatment of congestive heart failure.

van Kimmenade RR, Bakker JA, Crijns HJ, van Dieijen-Visser MP, Pinto YM.

Neth Heart J. 2004 Feb;12(2):61-63. Review.

8.

BNP was associated with ischemic myocardial scintigraphy and death in patients at chest pain unit.

Azevedo JC, Reis BC, Barreto NM, F Junior DS, Prezotti LS, Procaci VR, Octaviano VW, Volschan A, Mesquita ET, Mesquita CT.

Arq Bras Cardiol. 2015 Jan;104(1):16-23. doi: 10.5935/abc.20140175. Epub 2014 Nov 18. English, Portuguese.

9.

Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure.

Li QS, Liu FQ.

J Cardiothorac Surg. 2013 Nov 26;8:217. doi: 10.1186/1749-8090-8-217.

10.

Physiology and clinical significance of natriuretic hormones.

Chopra S, Cherian D, Verghese PP, Jacob JJ.

Indian J Endocrinol Metab. 2013 Jan;17(1):83-90. doi: 10.4103/2230-8210.107869.

11.

The biological variation of N-terminal pro-brain natriuretic peptide in postmenopausal women with type 2 diabetes: a case control study.

González S, Kilpatrick ES, Atkin SL.

PLoS One. 2012;7(11):e47191. doi: 10.1371/journal.pone.0047191. Epub 2012 Nov 9.

12.

Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?

Ozturk TC, Unluer E, Denizbasi A, Guneysel O, Onur O.

J Res Med Sci. 2011 Dec;16(12):1564-71.

13.

Serum high-sensitivity C-reactive protein, amyloid associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia.

Başkurt M, Aktürk F, Keskin K, Canbolat P, Karadag B, Kaya A, Yildiz A, Coskun U, Kilickesmez K, Esen O, Muniboglu SK.

Cardiovasc J Afr. 2011 Mar-Apr;22(2):85-9. doi: DOI: CVJ-21.027.

14.

Assessment of preoperative B-type natriuretic peptide in adult surgeries: is it useful?

Fox AA, Body SC.

Anesth Analg. 2011 May;112(5):1005-7. doi: 10.1213/ANE.0b013e318210c739. No abstract available.

15.

Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery.

Fox AA, Marcantonio ER, Collard CD, Thoma M, Perry TE, Shernan SK, Muehlschlegel JD, Body SC.

Anesthesiology. 2011 Apr;114(4):807-16. doi: 10.1097/ALN.0b013e31820ef9c1.

16.

Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.

Kozdag G, Ertas G, Kilic T, Acar E, Sahin T, Ural D.

Tex Heart Inst J. 2010;37(5):538-46.

17.

In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.

Di Somma S, Magrini L, Pittoni V, Marino R, Mastrantuono A, Ferri E, Ballarino P, Semplicini A, Bertazzoni G, Carpinteri G, Mulè P, Pazzaglia M, Shah K, Maisel A, Clopton P.

Crit Care. 2010;14(3):R116. doi: 10.1186/cc9067. Epub 2010 Jun 16.

18.

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Palazzuoli A, Gallotta M, Quatrini I, Nuti R.

Vasc Health Risk Manag. 2010 Jun 1;6:411-8. Review.

19.

Comparability of Results between Point-of-Care and Automated Instruments to Measure B-type Natriuretic Peptide.

Shah K, Terracciano GJ, Jiang K, Maisel AS, Fitzgerald RL.

West J Emerg Med. 2010 Feb;11(1):44-8.

20.

Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting.

Fox AA, Muehlschlegel JD, Body SC, Shernan SK, Liu KY, Perry TE, Aranki SF, Cook EF, Marcantonio ER, Collard CD.

Anesthesiology. 2010 Apr;112(4):842-51. doi: 10.1097/ALN.0b013e3181d23168.

Supplemental Content

Support Center